Joe Swedish, the chairman, President and CEO of Indianapolis-based Anthem, will be stepping down in his role as CEO of the company according to The Wall Street Journal.
The report says Swedish will be replaced as CEO by Gail Boudreaux, the former chief executive of UnitedHealth Group. The newspaper didn’t say when the transition would begin, but the plan is expected to be announced soon. Swedish could receive around US$26.5 million from Anthem upon his retirement.
Swedish became CEO of Anthem in 2013 after previous CEO Angela Braly was forced to leave the company as investors expressed their displeasure with how they felt she had been leading the company.
Anthem is the second-largest insurance provider in the United States. The company’s headquarters are on Monument Circle in Indianapolis.
Earlier this year, Anthem had planned a US$48 billion merger with Cigna until the deal was stopped by a federal judge who ruled that it would be a violation of antitrust laws. However, there were subsequent reports of disagreements between Swedish and Cigna’s CEO David Cordani over the terms of the merger. The two companies are engaged in an ongoing court battle seeking billions of dollars in damages since the merger was blocked.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas